Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
基本信息
- 批准号:7193518
- 负责人:
- 金额:$ 29.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:Anesthesia proceduresAnestheticsAnimalsAntibodiesAwarenessBehaviorBrainCathetersCell LineCellsCerebrumCharacteristicsClinicalCodeDataDoctor of MedicineDrug Binding SiteDrug DesignFamilyFamily memberGated Ion ChannelGene ExpressionGene SilencingGeneral AnesthesiaGeneral anesthetic drugsGenesGlutamatesGlycineGoalsGrantHeartHumanImplantIn Situ HybridizationIn VitroInvestigationIon ChannelLeadLigandsLinkMeasurementMediatingMediator of activation proteinMental DepressionMolecularMusMutateNamesNeuraxisNeuronsOperative Surgical ProceduresPatientsPatternPharmaceutical PreparationsPharmacologyPhenotypePolymerase Chain ReactionPotassium ChannelProteinsRNA InterferenceRangeRattusReportingResearchResearch PersonnelReverse TranscriptionRoleSiteSite-Directed MutagenesisSmall Interfering RNASourceSpinalSpinal CordStandards of Weights and MeasuresStereoisomerSystemTandem Pore Domain Potassium ChannelsTechniquesTemperatureTestingTissuesWorkXenopus oocytebrain tissuedepressive symptomsdimerimprovedin vivoknockout genemRNA Expressionmolecular modelingpotassium channel protein TREK-1potassium ionprogramsprotein expressionreceptorresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Anesthesia is a clinical state of central nervous system (CMS) depression produced by the systemic administration of a variety of drugs. Under anesthesia a patient has neither awareness, remembrance, nor response to the noxious stimulation of surgery. Despite more that 100 years of investigation, the mechanism(s) by which general anesthesia occurs remains unknown. The principal molecular candidates identified over the last 20-30 years are ion channels whose activities within the CMS may be modulated by anesthetic drugs to produce the anesthetic state. Substantial work investigating the role of ligand-gated ion channels such as GABAA, glycine, neuronal nicotinic, glutamate and serotonergic receptor channels in anesthesia mechanisms has been reported but has failed to convincingly prove an exclusive role. Ion channels that selectively pass potassium ions - K channels - represent another plausible anesthetic target. Insufficient investigation has taken place on K channels to understand their role in anesthetic mechanisms. Of the three main families of K channels, the tandem pore K (Kap) channel family has been the most recently discovered. Members of this family are responsible for baseline or background K currents that are important for regulating the excitability of neurons in the CNS. Currents passed by the major members of this family are potentiated by volatile general anesthetics, providing a plausible explanation for the CMS depression they produce. Preliminary data presented here show that the K2p channel named TRESK is uniquely activated by volatile anesthetics, making it a highly promising candidate for a site of volatile anesthetic action. In this grant we propose a detailed analysis of the pharmacology and expression pattern of human, mouse and rat TRESK. We also propose gene silencing experiments (using RNA interference) to alter TRESK expression in order to determine its involvement in the whole animal response to anesthetics. An understanding of the basic mechanisms underlying anesthesia has the potential to lead to improved anesthetic drugs or techniques.
描述(申请人提供):麻醉是中枢神经系统(CMS)抑郁的一种临床状态,由各种药物的全身给药产生。在麻醉状态下,病人对手术的有害刺激既没有知觉,也没有记忆,也没有反应。尽管进行了100多年的研究,但全身麻醉发生的机制(S)仍不清楚。在过去20-30年中确定的主要候选分子是离子通道,其在CMS内的活动可能被麻醉药物调节以产生麻醉状态。已有大量工作报道了配体门控离子通道,如GABAA、甘氨酸、神经元烟碱、谷氨酸和5-羟色胺能受体通道在麻醉机制中的作用,但未能令人信服地证明其具有排他性作用。选择性地通过钾离子的离子通道--K通道--是另一个看似合理的麻醉剂靶点。对K通道的研究还不充分,无法了解它们在麻醉机制中的作用。在K通道的三个主要家族中,串联孔K(Kap)通道家族是最新发现的。这个家族的成员负责基线或背景K电流,这对调节中枢神经系统神经元的兴奋性很重要。这个家族的主要成员传递的电流被挥发性全麻药增强,为他们产生的CMS抑郁提供了一个可信的解释。这里提供的初步数据显示,名为Tresk的K2p通道唯一地被挥发性麻醉剂激活,使其成为非常有希望的挥发性麻醉作用部位的候选者。在这项资助中,我们建议对人、小鼠和大鼠Tresk的药理和表达模式进行详细分析。我们还提出了基因沉默实验(使用RNA干扰)来改变Tresk的表达,以确定其参与整个动物对麻醉剂的反应。对麻醉的基本机制的了解有可能导致改进麻醉药物或技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES S YOST其他文献
CHARLES S YOST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES S YOST', 18)}}的其他基金
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
- 批准号:
6019491 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
POTASSIUM CHANNEL ACTIVATION BY VOLATILE ANESTHETICS
挥发性麻醉剂激活钾通道
- 批准号:
6519882 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
- 批准号:
2686327 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
POTASSIUM CHANNEL ACTIVATION BY VOLATILE ANESTHETICS
挥发性麻醉剂激活钾通道
- 批准号:
6386892 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
- 批准号:
2909120 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
- 批准号:
6525464 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
- 批准号:
7031283 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
- 批准号:
6181120 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
- 批准号:
6370601 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
- 批准号:
6651987 - 财政年份:1998
- 资助金额:
$ 29.36万 - 项目类别:
相似海外基金
Investigation of the mechanism of recovery effect of anesthetics on endothelial glycocalyx damage
麻醉药对内皮糖萼损伤恢复作用的机制探讨
- 批准号:
23K08341 - 财政年份:2023
- 资助金额:
$ 29.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of a Novel Functional Mechanism of Intravenous Anesthetics Based on the Membrane Lipid Theory and Its Application to Clinical Practice
基于膜脂理论的静脉麻醉药新作用机制的阐明及其在临床实践中的应用
- 批准号:
23K06361 - 财政年份:2023
- 资助金额:
$ 29.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
- 批准号:
10657509 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Electrophysiological analysis of proarrhythmic properties of volatile anesthetics using an originally developed arrhythmogenic model
使用最初开发的致心律失常模型对挥发性麻醉药的致心律失常特性进行电生理分析
- 批准号:
22K09032 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modification of the intercellular network of immune cells in tumor microenvironment by sedatives and anesthetics.
通过镇静剂和麻醉剂改变肿瘤微环境中免疫细胞的细胞间网络。
- 批准号:
22K09083 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of astrocytes in emergence from volatile anesthetics
星形胶质细胞在挥发性麻醉剂苏醒中的作用
- 批准号:
10340339 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics
全身麻醉药代际神经行为效应的机制和血液生物标志物
- 批准号:
10538703 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
- 批准号:
10440005 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
- 批准号:
10870632 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
- 批准号:
10671023 - 财政年份:2022
- 资助金额:
$ 29.36万 - 项目类别: